Statistics for BioForce Nanosciences Holdings, (id:11400 BFNH)
Valuation metrics
Market cap
31.91M
Enterprise value
0.00
Trailing P/E (ttm)
-33.75
Forward P/E
PEG ratio
Price/Sales (ttm)
Price/Book (mrq)
-9.57
Enterprise Value/Revenue
Enterprise Value/EBITDA
0.00
Overview
Shares outstanding
29.27M
Float
Shares short
% Held by insiders
0.86%
% Held by institutions
0.00%
Average volume (10 days)
2.15K
Average volume (90 days)
Price summary
52-Week low
0.16
52-Week high
2.30
52-Week change
-240.74%
Beta
50-Day moving average
1.08
200-Day moving average
1.37
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
February 28th, 2020
Ex-dividend date
Last split factor
2:1
Last split date
February 28th, 2020
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
June 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-73,973.82%
Return on equity
25.94%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
0.00
Net income to common (ttm)
-471,953.00
Diluted EPS (ttm)
-0.02
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
667.00
Total cash per share (mrq)
0.00
Total debt (mrq)
0.00
Total Debt/Equity (mrq)
0.00
Current ratio (mrq)
0.03%
Book value per share (mrq)
-0.06
Cash flow
Cash flow statement
-469,702.00
Levered free cash flow (LFCF)
-471,953.00